Endothelial-derived nitric oxide (EDNO) modulates vascular tone, platelet aggregation, and smooth muscle cell proliferation. Alteration of its release has been implicated in several models of atherogenesis, but he mechanism(s) by which this occurs remain unknown. Recent evidence suggest that lipoproteins an inhibit EDNO release and activate neuclear binding of this research proposal is to explore possible mechanism(s0 of how lipoproteins alter G-protein expression and/or function in bovine aortic endothelial cells. We will characterize the acute and chronic effects of lipoproteins on EDNO release in bovine aortic endothelial cells and determine whether lipoprotein treatment affects the expression of alphas, alphai2,3,alphaq/11,beta1-4,gamma1-3 subunit and nitric oxide synthase. Several classes of lipoproteins (LDL, VLDL, HDL) as well as serum from hyperlipidemic patients will be examined. The effects of lipoproteins on alpha2-adrenergic, beta2-adrenergic and bradykinin receptor-G-protein coupling will be assessed by the formation of high-affinity agonist binding sites and agonist-stimulated GTP hydrolysis. The effects of lipoproteins on G-protein-phospholipase C will be assessed by phosphatidylinositol 4,5- bisphosphate hydrolysis and increases in intracellular calcium by Fura-2 AM fluorescence. The effects of lipoproteins on G-protein adenylyl cyclase coupling will be assessed by forskolin and cAMP assays. Finally, for the G-protein components which are affected y lipoproteins, we will overexpress these components (alpha, beta, and gamma subunits) and nitric oxide synthase in cultured bovine aortic endothelial cells and NIH3T3 fibroblasts to determine if G-protein function and EDNO release can be restored in the presence of lipoprotein treatment. Both transient and stable transfections will be attempted using the endothelin and a variety of available viral promoters. This project will help create a better understanding of how lipoproteins can affect G-protein-mediated processes such as EDNO release and NF-kappaB activation . Inhibition of EDNO release and activation of NF-kappaB may mediate some of the atherogenic effects of lipoproteins. Thus, by knowing the mechanism(s0 behind how lipoproteins alter G-protein function, we may gain greater insight into how hypercholesterolemia can produce changes in vascular function and predispose to atherosclerosis. This may ultimately lead to therapeutic modalities which can restore vascular function through enhancing G-protein interaction with its receptors and effectors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL052233-01A2
Application #
2229505
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1995-07-01
Project End
2000-05-31
Budget Start
1995-07-01
Budget End
1996-05-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Hiroi, Yukio; Noma, Kensuke; Kim, Hyung-Hwan et al. (2018) Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice. Circ J 82:1195-1204
Liao, James K; Oesterle, Adam (2018) The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr Vasc Pharmacol :
Tabit, Corey E; Coplan, Mitchell J; Chen, Phetcharat et al. (2018) Tumor necrosis factor-? levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant 37:107-115
Tabit, Corey E; Coplan, Mitchell J; Spencer, Kirk T et al. (2017) Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure. Am J Med 130:1112.e17-1112.e31
Sladojevic, Nikola; Oh, Goo Taeg; Kim, Hyung-Hwan et al. (2017) Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. Cardiovasc Res 113:1307-1317
Kasahara, D I; Mathews, J A; Ninin, F M C et al. (2017) Role of ROCK2 in CD4+ cells in allergic airways responses in mice. Clin Exp Allergy 47:224-235
Shimizu, Toru; Narang, Nikhil; Chen, Phetcharat et al. (2017) Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. JCI Insight 2:
Sladojevic, Nikola; Yu, Brian; Liao, James K (2017) ROCK as a therapeutic target for ischemic stroke. Expert Rev Neurother 17:1167-1177
Mazurek, Stefan; Kim, Gene H (2017) Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy. Biochim Biophys Acta Mol Basis Dis 1863:2064-2069
Oesterle, Adam; Laufs, Ulrich; Liao, James K (2017) Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res 120:229-243

Showing the most recent 10 out of 150 publications